CYPCYNATA THERAPEUTICS LIMITED
Announcement history available from 1 August 2025
Fromto
| Date / Time | Title | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 30 July 2026, 21:02 | June 2026 Quarterly Activity Report & Appendix 4C | Quarterly Reports | MS | 19004, 19009 | |
| 10 July 2026, 18:38 | Notification of cessation of securities - CYP | Other | — | 06027 | |
| 6 July 2026, 18:37 | Final Director's Interest Notice | Director Interests | — | 02010 | |
| 6 July 2026, 18:35 | Board, Management Changes, Expenditure Reductions, RDTI Loan | Capital Raising | MS | 03022, 12001, 12008, 12019 | |
| 3 July 2026, 04:31 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 2 July 2026, 18:15 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 30 June 2026, 18:57 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 24 June 2026, 01:47 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 22 June 2026, 18:19 | Investor Webinar | Presentations | — | 03026, 14014 | |
| 19 June 2026, 19:22 | Reinstatement to Official Quotation | Reinstatement | MS | 09002 | |
| 19 June 2026, 19:22 | CYP-004 Osteoarthritis Trial Results | Company Update | MS | 11001, 14014 | |
| 17 June 2026, 22:05 | CYP-001 GvHD Trial Primary Evaluation Results | Company Update | MS | 11001 | |
| 16 June 2026, 18:53 | Suspension from Quotation | Trading Halt / Suspension | MS | 09001 | |
| 12 June 2026, 19:46 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 3 June 2026, 18:48 | EU Positive Opinion on CYP-001 Paediatric Investigation Plan | Company Update | MS | 11001 | |
| 29 May 2026, 18:56 | WHO Selects Proposed INN for Cymerus MSCs | Company Update | — | 11001 | |
| 27 May 2026, 18:54 | Expected Timing of Clinical Trial Results | Company Update | — | 11001 | |
| 8 May 2026, 19:01 | Cleansing Notice | Securities Administration | — | 06018 | |
| 8 May 2026, 18:57 | Application for quotation of securities - CYP | Other | — | 06020 | |
| 4 May 2026, 19:05 | Proposed issue of securities - CYP | Securities Administration | — | 06013 | |
| 4 May 2026, 19:05 | Cynata Secures Commitments for $1.5m Placement | Capital Raising | MS | 03026, 06003, 09014 | |
| 30 Apr 2026, 20:00 | March 2026 Quarterly Activity Report & Appendix 4C | Quarterly Reports | MS | 19003, 19008 | |
| 30 Apr 2026, 19:03 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 7 Apr 2026, 18:31 | Notification of cessation of securities - CYP | Other | — | 06027 | |
| 30 Mar 2026, 19:58 | Last Visit in GvHD Trial Completed | Company Update | MS | 11001 | |
| 27 Feb 2026, 02:43 | Appendix 4D & Half-Year Financial Statements | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 5 Feb 2026, 20:29 | Cynata to Present at 2026 Euroz Hartleys Healthcare Forum | Presentations | — | 03026 | |
| 4 Feb 2026, 20:05 | Investor Webinar | Presentations | — | 03026, 14014 | |
| 29 Jan 2026, 20:30 | December 2025 Quarterly Activity Report and Appendix 4C | Quarterly Reports | MS | 19002, 19007 | |
| 24 Jan 2026, 04:41 | Cynata Completes $1.2m At-The-Market Raise | Securities Administration | MS | 06009 | |
| 15 Dec 2025, 20:09 | Patient Enrolment Complete in Phase 2 aGvHD Clinical Trial | Company Update | MS | 11001 | |
| 4 Dec 2025, 19:56 | Positive DSMB Review in Phase 1/2 Kidney Transplant Trial | Company Update | MS | 11001 | |
| 1 Dec 2025, 19:48 | Appendix 3Y - Dr Paul Wotton | Director Interests | — | 02009 | |
| 1 Dec 2025, 19:46 | Appendix 3Y - Dr Darryl Maher | Director Interests | — | 02009 | |
| 1 Dec 2025, 19:45 | Appendix 3Y - Dr Geoff Brooke | Director Interests | — | 02009 | |
| 1 Dec 2025, 19:39 | Notification of cessation of securities - CYP | Other | — | 06027 | |
| 24 Nov 2025, 20:24 | Final Patient Visit Complete in Phase 3 Osteoarthritis Trial | Company Update | MS | 11001 | |
| 17 Nov 2025, 19:53 | Investor Presentation | Presentations | — | 03026 | |
| 13 Nov 2025, 22:37 | Results of Annual General Meeting | Meetings & Governance | — | 08003 | |
| 13 Nov 2025, 19:22 | AGM Presentations | Presentations | — | 03026, 15002 | |
| 6 Nov 2025, 19:54 | Investor Webinar | Presentations | — | 03026, 14014 | |
| 5 Nov 2025, 23:14 | Cynata Receives $1.7m R&D Tax Incentive Refund | Periodic Reports | MS | 03014, 12008 | |
| 1 Nov 2025, 00:36 | September 2025 Quarterly Activity Report and Appendix 4C | Quarterly Reports | MS | 19001, 19006 | |
| 13 Oct 2025, 19:55 | Notification of cessation of securities - CYP | Other | — | 06027 | |
| 11 Oct 2025, 03:44 | Annual Report to Shareholders | Financial Results | — | 03001, 03002, 03011, 03012, 03013, 03020 | |
| 11 Oct 2025, 03:41 | Letter to Shareholders, Notice of AGM and Proxy Form | Meetings & Governance | — | 08001, 08004, 16002 | |
| 18 Sept 2025, 18:28 | Date of AGM & Closing Date for Director Nominations | Meetings & Governance | — | 08006 | |
| 29 Aug 2025, 04:24 | Appendix 4G | Company Administration | — | 03025 | |
| 29 Aug 2025, 04:23 | Corporate Governance Statement | Company Administration | — | 03024 | |
| 29 Aug 2025, 04:23 | Appendix 4E & Annual Report | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 |
1–50 of 55
1 / 2